Company
Kiniksa Pharmaceuticals
Kiniksa Pharmaceuticals has 6 drugs tracked on RxWires: 1 in Phase 3, 2 in Phase 2/3, 3 in Phase 2.
Pipeline
| Drug | Phase | Indication |
|---|---|---|
| Rilonacept | Phase 3 | Recurrent Pericarditis |
| mavrilimumab | Phase 2/3 | COVID |
| KPL-387 | Phase 2/3 | Pericarditis |
| KPL-404 | Phase 2 | Arthritis, Rheumatoid |
| Abiprubart | Phase 2 | Sjögrens Disease |
| KPL-914 | Phase 2 | Recurrent Pericarditis |
Latest
- kiniksa pharmaceuticals filed 8-K
- kiniksa pharmaceuticals filed 8-K
- kiniksa pharmaceuticals filed 8-K
- kiniksa pharmaceuticals filed 8-K
- kiniksa pharmaceuticals filed 8-K
Follow Kiniksa Pharmaceuticals on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.